Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 2/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.38 |
| ▸ | ACACB | O00763 | 8/20 | 0.36 |
| ▸ | ACACA | Q13085 | 8/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.35 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31428613 | 0.96 | PDCD1 (0.38) | PDCD1CD274ACACBACACAALDH1A1 | |
| SCHEMBL31428556 | 0.93 | PDCD1 (0.37) | PDCD1CD274ACACBACACAALDH1A1 | |
| SCHEMBL31428701 | 0.92 | ALDH1A1 (0.35) | PDCD1CD274ACACBACACAALDH1A1 | |
| SCHEMBL31428450 | 0.91 | ACACB (0.34) | PDCD1CD274ACACBACACAALDH1A1 | |
| SCHEMBL31429054 | 0.89 | LRRK2 (0.34) | ALDH1A1MAPTMAPK1HTTSMN1; SMN2 | |
| SCHEMBL31428666 | 0.89 | PDCD1 (0.48) | PDCD1CD274ALDH1A1MAPTMAPK1 | |
| SCHEMBL31428769 | 0.89 | LRRK2 (0.34) | PDCD1CD274ACACBALDH1A1MAPT | |
| SCHEMBL31428454 | 0.89 | ALDH1A1 (0.47) | PDCD1CD274ALDH1A1MAPTMAPK1 | |
| SCHEMBL31428674 | 0.87 | ALDH1A1 (0.40) | PDCD1CD274ACACBACACAALDH1A1 | |
| SCHEMBL31428831 | 0.86 | HPGD (0.40) | PDCD1CD274ACACBACACAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091994-A1 | RAS/RAF BINDING INHIBITOR COMPOUND | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2025-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250091994-A1 | RAS/RAF BINDING INHIBITOR COMPOUND | BRAF, RAF1, NRAS | PDCD1 1360/4885CD274 1903/4885ACACB 3303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.